+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mechanical Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • PDF Icon

    Report

  • 42 Pages
  • June 2022
  • Region: Global
  • GlobalData
  • ID: 5640128
The publisher's Medical Devices sector report, “Mechanical Heart Valves Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update' provides comprehensive information about the Mechanical Heart Valves pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Mechanical heart valves are generally made of non-physiological materials with a mobile occluder, which is made of rigid materials.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Mechanical Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Mechanical Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy


The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Mechanical Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Mechanical Heart Valves Overview
3 Products under Development
3.1 Mechanical Heart Valves - Pipeline Products by Stage of Development
3.2 Mechanical Heart Valves - Pipeline Products by Segment
3.3 Mechanical Heart Valves - Pipeline Products by Territory
3.4 Mechanical Heart Valves - Pipeline Products by Regulatory Path
3.5 Mechanical Heart Valves - Pipeline Products by Estimated Approval Date
3.6 Mechanical Heart Valves - Ongoing Clinical Trials
4 Mechanical Heart Valves - Pipeline Products under Development by Companies
4.1 Mechanical Heart Valves Companies - Pipeline Products by Stage of Development
4.2 Mechanical Heart Valves - Pipeline Products by Stage of Development
5 Mechanical Heart Valves Companies and Product Overview
5.1 Artivion Inc Company Overview
5.2 Autus Valve Technologies Inc Company Overview
5.3 Innovator Lab Consultants India Pvt Ltd Company Overview
5.4 Innovia LLC Company Overview
5.5 Meril Life Sciences Pvt Ltd Company Overview
5.6 On-X Life Technologies Inc Company Overview
5.7 Shanghai Aoliu Medical Technology Co Ltd Company Overview
5.8 TTK Healthcare Ltd Company Overview
5.9 University of Pittsburgh Medical Center Company Overview
6 Mechanical Heart Valves- Recent Developments
6.1 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results
6.2 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase
6.3 Apr 01, 2022: Japan Lifeline Announces a New Appointment of Operating Officer
6.4 Jan 28, 2022: Japan Lifeline Co. Announces Consolidated Financial Results for the Nine months Ended December 31, 2021
6.5 Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
6.6 Nov 01, 2021: Japan Lifeline Announces FY3/2022 2Q Financial Results
6.7 Aug 04, 2021: Japan Lifeline Announces FY3/2022 1Q Financial Results
6.8 Jul 14, 2021: Inappropriate anticoagulation of patients with a mechanical heart valve
6.9 Jun 25, 2021: Japan Lifeline Notice of Resolution of the 41st Annual General Meeting of Shareholders
7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Mechanical Heart Valves - Pipeline Products by Stage of Development
  • Mechanical Heart Valves - Pipeline Products by Segment
  • Mechanical Heart Valves - Pipeline Products by Territory
  • Mechanical Heart Valves - Pipeline Products by Regulatory Path
  • Mechanical Heart Valves - Pipeline Products by Estimated Approval Date
  • Mechanical Heart Valves - Ongoing Clinical Trials
  • Mechanical Heart Valves Companies - Pipeline Products by Stage of Development
  • Mechanical Heart Valves - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Mechanical Heart Valves - Pipeline Products by Stage of Development
  • Mechanical Heart Valves - Pipeline Products by Segment
  • Mechanical Heart Valves - Pipeline Products by Territory
  • Mechanical Heart Valves - Pipeline Products by Regulatory Path
  • Mechanical Heart Valves - Pipeline Products by Estimated Approval Date
  • Mechanical Heart Valves - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Artivion Inc
  • Autus Valve Technologies Inc
  • Innovator Lab Consultants India Pvt Ltd
  • Innovia LLC
  • Meril Life Sciences Pvt Ltd
  • On-X Life Technologies Inc
  • Shanghai Aoliu Medical Technology Co Ltd
  • TTK Healthcare Ltd
  • University of Pittsburgh Medical Center